Brinker Capital Investments’s Acceleron Pharma XLRN Stock Holding History

Brinker Capital Investments’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,239	Closed	-$1.79M	–	1463
2021 Q3	$1.79M	Hold	14,239	–	–	0.03%	584
2021 Q2	$1.79M	Buy	14,239 +1,178	+9%	+$149K	0.02%	639
2021 Q1	$1.77M	Sell	13,061 -11,967	-48%	-$1.55M	0.03%	545
2020 Q4	$3.2M	Buy	25,028 +11,767	+89%	+$1.38M	0.05%	442
2020 Q3	$1.49M	Buy	+13,261	New	+$1.32M	0.03%	566

Brinker Capital Investments's XLRN Position: Q4 2021 in Review

Brinker Capital Investments sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 14,239 shares — an estimated $1.79M sold.

Brinker Capital Investments first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $3.2M in Q4 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Brinker Capital Investments reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Brinker Capital Investments sold 14,239 Acceleron Pharma shares in Q4 2021, an estimated $1.79M.
Brinker Capital Investments first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
Brinker Capital Investments's Acceleron Pharma position peaked at $3.2M in Q4 2020.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Brinker Capital Investments's 13F filing for Q4 2021, filed 8 Feb 2022.